All the news Showing 10 of 217 articles from: Pharmaceutical industryGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Government's patent grant to Gilead challenged in Delhi High Court Economic Times / 17 May 2016 Gilead patent to hit millions of patients outside India DNA India / 17 May 2016 Grant of patent will not lead to any increase in Sovaldi pricing: Gregg Alton Economic Times / 16 May 2016 Europe delays Merck & Co.'s HCV drug on back of CMO quality issues In-Pharmatechnologist / 11 May 2016 Sky-high price of hepatitis C drug produces profits for lawmakers Center for Responsive Politics / 05 May 2016 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier Fierce Pharma / 03 May 2016 Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV in Africa and Asia World Hepatitis Alliance / 14 April 2016 Gilead acquires NASH drug development program Healio Hepatology / 05 April 2016 Mortgages For Expensive Health Care? Some Experts Think It Can Work Kaiser Health News / 29 March 2016 Merck Wins Chance for Royalties on Gilead’s Hepatitis C Cure Bloomberg / 24 March 2016 ← Prev1...89101112...22Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Noticeboard Email bulletins News feeds